Special Issue "Advances in the Radiography of Prostate Cancer"
A special issue of Tomography (ISSN 2379-139X).
Deadline for manuscript submissions: 30 December 2022 | Viewed by 438
Today, PET/CT has a profound influence on diagnostic work in prostate cancer, where MR alone was the leading technology for a decade. Today, multimodality imaging is striving to find the correct balance between cost and benefit. The possibility of PET/MR has not, or not yet, resulted in a major change to this modality. This may be due both to the relative paucity of PET/MR and inherent difficulties in the technology.
On top of technological advances, we can observe a multitude of other possibilities that are invading our field. A number of PET tracers are used or under development. An impressive number of PSMA analogues, based on generator-based 67Ga-gallium or cyclotron-based 18F-flour, are under development. The last word on their respective sensitivity and specificity has not yet been uttered.
Not least, the new treatment possibility with protein receptor radionuclides has produced amazing results in clinical trials, and they are on the verge of marketing authorization, possibly changing the prognosis of a vast number of patients.
There is a plentitude of potential new knowledge, leaving us with a number of stones unturned, hence this Special Issue.
Papers of high academic standard addressing these and related topics are invited to this Special Issue. We are looking for results from clinical and preclinical studies and papers identifying unmet needs or challenges related to the field of imaging and nuclear-medicine-based therapeutics.
Dr. Tore Bach-Gansmo
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Tomography is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 1800 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
- prostate cancer
- PSMA therapeutic use